Rare diseases
Investigational molecules
Locations
Long-term Safety and Efficacy of Remibrutinib in Adults with Moderate to Severe Hidradenitis Suppurativa
GreeceBI 764198 in Adults and Adolescents with Proteinuric Kidney Diseases
GreeceOrelabrutinib in Patients with Primary Progressive Multiple Sclerosis
GreeceStudy of Zenagamtide (NNC0487-0111) versus placebo in patients with heart failure with preserved or mildly reduced ejection fraction and obesity
GreeceA study to evaluate the efficacy and safety of depemokimab and salbutamol sulfate in patients with chronic obstructive pulmonary disease and type 2 inflammation.
GreeceA study to evaluate the effects of BI 764198 in adults and adolescents with focal segmental glomerulosclerosis (FSGS)
GreeceA study to evaluate the long-term safety and effectiveness of barzolvolimab in patients with chronic spontaneous urticaria
GreeceStudy of sotorasib, panitumumab and a drug combination for patients with metastatic colorectal cancer with KRAS p.G12C mutation.
GreeceA study to evaluate the effectiveness and safety of duvakitug in patients with moderate to severe Crohn's disease
GreeceA study to evaluate the efficacy and safety of duvakitug in patients with moderate to severe Crohn's disease
GreeceA Study Comparing Empasiprubart Versus Intravenous Immunoglobulin in Adults With Chronic Inflammatory Demyelinating Polyneuropathy
GreeceA study to evaluate the safety of dazodalibep in patients with Sjögren's Syndrome over a long period of time
GreeceTell us about your condition – we search every trial in Europe and connect you with the right site.
